常州市存仁生物工程有限公司

新聞

聯(lián)系我們

電話(huà): +86-519-85788828
傳真: +86-519-89960117
E-mail: sales@chemrenpharm.com
地址: 江蘇省常州市新北區百丈工業(yè)園
QQ: 2500035664

Erlotinib hydrochloride|埃羅替尼

Description of:Erlotinib hydrochloride|埃羅替尼
Erlotinib is an inhibitor of human Epidermal growth factor receptor (EGFR) tyrosine kinase (IC50 = ...

Description of:AST-6
AST-6, a rationally designed novel anilino-quinazoline compound, inhibited enzymatic activities of wild type EGFR and ErbB...

Description of:TAK 285
TAK-285 is currently under clinical development. TAK-285 may have a unique role in the treatment of brain lesions ...

Description of:AEE788
AEE788 demonstrated antiproliferative activity against a range of EGFR and ErbB2-overexpressing cell lines and inhibited ...

Description of:CUDC-101
This drug has novel structure incorporating HDAC inhibitory functionality into the pharmacophore of the EGFR and ...

Description of:Afatinib
Afatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
Theor...

Description of:BMS690514
BMS-690514 is currently under investigation as an oral agent for the treatment of solid tumors. In vitro and in vivo s...

Description of:AG-490
AG490 inhibits the proliferation of several cell types including leukemia cells and fibroblasts. AG490 is also selective ...

總數: 8 頁(yè): 1 / 1 首頁(yè) ←上一頁(yè) 下一頁(yè)→ 末頁(yè)